Safety and Efficacy of Faricimab in Patients With NPDR

NCT05681884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

179

Enrollment

OTHER

Sponsor class

Conditions

Non-Proliferative Diabetic Retinopathy

Interventions

DRUG: Faricimab

Sponsor

Greater Houston Retina Research

Collaborators

[object Object]